Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
Purpose: Tranexamic acid (TXA) is prescribed for short term management of haemorrhage. It is also administered prophylatically in surgeries where blood loss is anticipated. Tranexamic mouth washes are also used in oral surgical procedures for patients with coagulopathies. The purpose of this study...
Main Authors: | Abu Dakir, Balakrishnan Ramalingam, Vijay Ebenezer, Prakash Dhanavelu |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2014-05-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/4313/8680_CE(Ra)_F(P)_PF1(PAK)_PFA(P)_PF2(PAG)_PF2(PN).pdf |
Similar Items
-
Outcomes of tranexamic acid administration in military trauma patients with intracranial hemorrhage: a cohort study
by: Patrick F. Walker, et al.
Published: (2020-05-01) -
The impact of prehospital tranexamic acid on mortality and transfusion requirements: match-pair analysis from the nationwide German TraumaRegister DGU®
by: Sebastian Imach, et al.
Published: (2021-08-01) -
Is There a Synergistic Effect of Topical Plus Intravenous Tranexamic Acid Versus Intravenous Administration Alone on Blood Loss and Transfusions in Primary Total Hip and Knee Arthroplasties?
by: Brian P. Chalmers, MD, et al.
Published: (2021-02-01) -
Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series
by: Fatimah Alabdrabalnabi, et al.
Published: (2020-08-01) -
Geographical Variance in the Use of Tranexamic Acid for Major Trauma Patients
by: Kieran Walsh, et al.
Published: (2019-09-01)